Relay Therapeutics Inc. reports fourth-quarter earnings Thursday, with analysts expecting a narrower loss as the clinical-stage biotech rides momentum from a major regulatory win. Analysts expect the ...
Relay Therapeutics, Inc. (NASDAQ:RLAY), a biotechnology company leveraging its platform to decode protein behavior for drug development, stands at a critical juncture in its journey. With a focus on ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する